Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study.
Esophageal motility disorders
Pulmonary fibrosis
Systemic sclerosis
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
05 Aug 2023
05 Aug 2023
Historique:
received:
14
06
2023
accepted:
19
07
2023
medline:
6
8
2023
pubmed:
6
8
2023
entrez:
5
8
2023
Statut:
aheadofprint
Résumé
Systemic sclerosis (SSc) is a rare autoimmune disease of the connective tissue that can affect multiple organs. The esophagus is the most affected gastrointestinal tract, while interstitial lung disease (ILD) is a main feature associated with SSc. The aim of the present study was to evaluate the association and prognostic implication between motor esophageal disorders and pulmonary involvement in SSc patients. We retrospectively assessed patients with SSc who underwent both the HRM with the new Chicago Classification 4.0 and pulmonary evaluation comprehensive of function tests and high-resolution computer tomography (HrCT) with the use of Warrick score. A total score ≥ 7 was considered predictive of ILD, while a score ≥ 10 in a HrCT acquired prospectively from baseline evaluation was considered to establish significant interstitial involvement. Forty-two patients were included. We found a score ≥ 7 in 11 patients with aperistalsis, in 6 subjects with IEM and in 6 patients with a normal manometry. Otherwise, a score < 7 was observed in 3 patients with aperistalsis, and in 2 and 14 patients with IEM and with a normal contractility, respectively. Higher scores were observed in subjects with absent contractility or ineffective esophageal motility than subjects with normal motility, indeed DCI and HrCT score were inversely correlated in linear and logarithmic regression analysis. Prospectively, lower baseline LESP and greater HrCT scores at follow-up evaluation were significantly correlated. This study shows an association between motor esophageal disorder and pulmonary involvement in SSc patients: more severe is the esophageal involvement, more critical is the pulmonary disease.
Identifiants
pubmed: 37542603
doi: 10.1007/s00296-023-05399-y
pii: 10.1007/s00296-023-05399-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Volkmann ER, Tashkin DP, Leng M et al (2022) Association of symptoms of gastroesophageal reflux, esophageal dilation, and progression of systemic sclerosis-related interstitial lung disease. Arthritis Care Res. https://doi.org/10.1002/acr.25070
doi: 10.1002/acr.25070
Savarino E, Mei F, Parodi A et al (2013) Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatol Oxf Engl 52:1095–1100. https://doi.org/10.1093/rheumatology/kes429
doi: 10.1093/rheumatology/kes429
Matsuda R, Yamamichi N, Shimamoto T et al (2018) Gastroesophageal reflux disease-related disorders of systemic sclerosis based on the analysis of 66 patients. Gastroenterologia 98:201–208. https://doi.org/10.1159/000489848
doi: 10.1159/000489848
van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747. https://doi.org/10.1002/art.38098
doi: 10.1002/art.38098
pubmed: 24122180
pmcid: 3930146
Roofeh D, Jaafar S, Vummidi D, Khanna D (2019) Management of systemic sclerosis-associated interstitial lung disease. Curr Opin Rheumatol 31:241–249. https://doi.org/10.1097/BOR.0000000000000592
doi: 10.1097/BOR.0000000000000592
pubmed: 30870216
pmcid: 6647025
Winstone TA, Assayag D, Wilcox PG et al (2014) Predictors of mortality and progression in scleroderma-associated interstitial lung disease. Chest 146:422–436. https://doi.org/10.1378/chest.13-2626
doi: 10.1378/chest.13-2626
pubmed: 24576924
Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C et al (2015) Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death. Medicine (Baltimore) 94:e1728. https://doi.org/10.1097/MD.0000000000001728
doi: 10.1097/MD.0000000000001728
pubmed: 26512564
Cottin V, Brown KK (2019) Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res 20:13. https://doi.org/10.1186/s12931-019-0980-7
doi: 10.1186/s12931-019-0980-7
pubmed: 30658650
pmcid: 6339436
Arif T, Masood Q, Singh J, Hassan I (2015) Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study. BMC Gastroenterol 15:24. https://doi.org/10.1186/s12876-015-0241-2
doi: 10.1186/s12876-015-0241-2
pubmed: 25888470
pmcid: 4339256
Hershcovici T, Jha LK, Johnson T et al (2011) Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 34:1295–1305. https://doi.org/10.1111/j.1365-2036.2011.04870.x
doi: 10.1111/j.1365-2036.2011.04870.x
pubmed: 21999527
Kuribayashi S, Motegi S-I, Hara K et al (2019) Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis. J Gastroenterol 54:950–962. https://doi.org/10.1007/s00535-019-01578-6
doi: 10.1007/s00535-019-01578-6
pubmed: 30937625
Schutyser W, Cruyt L, Vulsteke J-B et al (2020) The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review. Clin Rheumatol 39:149–157. https://doi.org/10.1007/s10067-019-04794-w
doi: 10.1007/s10067-019-04794-w
pubmed: 31709478
Kimmel JN, Carlson DA, Hinchcliff M et al (2016) The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 28:1157–1165. https://doi.org/10.1111/nmo.12813
doi: 10.1111/nmo.12813
Yadlapati R, Kahrilas PJ, Fox MR et al (2021) Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 33:e14058. https://doi.org/10.1111/nmo.14058
doi: 10.1111/nmo.14058
Savarino E, de Bortoli N, Bellini M et al (2016) Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver 48:1124–1135. https://doi.org/10.1016/j.dld.2016.06.021
doi: 10.1016/j.dld.2016.06.021
Rengarajan A, Rogers BD, Wong Z et al (2022) High-resolution manometry thresholds and motor patterns among asymptomatic individuals. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 20:e398–e406. https://doi.org/10.1016/j.cgh.2020.10.052
doi: 10.1016/j.cgh.2020.10.052
Diot E, Boissinot E, Asquier E et al (1998) Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis. Chest 114:1623–1629. https://doi.org/10.1378/chest.114.6.1623
doi: 10.1378/chest.114.6.1623
pubmed: 9872198
Li B, Yan J, Pu J et al (2021) Esophageal Dysfunction in Systemic Sclerosis: An Update. Rheumatol Ther 8:1535–1549. https://doi.org/10.1007/s40744-021-00382-0
doi: 10.1007/s40744-021-00382-0
pubmed: 34628599
pmcid: 8572301
Fox MR, Bredenoord AJ (2008) Oesophageal high-resolution manometry: moving from research into clinical practice. Gut 57:405–423. https://doi.org/10.1136/gut.2007.127993
doi: 10.1136/gut.2007.127993
pubmed: 17895358
Carlson DA, Crowell MD, Kimmel JN et al (2016) Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 14:1502–1506. https://doi.org/10.1016/j.cgh.2016.03.039
doi: 10.1016/j.cgh.2016.03.039
Denaxas K, Ladas SD, Karamanolis GP (2018) Evaluation and management of esophageal manifestations in systemic sclerosis. Ann Gastroenterol 31:165–170. https://doi.org/10.20524/aog.2018.0228
doi: 10.20524/aog.2018.0228
pubmed: 29507463
pmcid: 5825946
Savarino E, Bazzica M, Zentilin P et al (2009) Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 179:408–413. https://doi.org/10.1164/rccm.200808-1359OC
doi: 10.1164/rccm.200808-1359OC
pubmed: 19096004
Bassotti G, Battaglia E, Debernardi V et al (1997) Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum 40:2252–2259. https://doi.org/10.1002/art.1780401222
doi: 10.1002/art.1780401222
pubmed: 9416865
Kuchipudi N, Kishore S, Kuo C-L et al (2019) Sat0280 esophageal dysmotility and pulmonary disease in patients with scleroderma: a retrospective study. Ann Rheum Dis 78:1217–1217. https://doi.org/10.1136/annrheumdis-2019-eular.1843
doi: 10.1136/annrheumdis-2019-eular.1843
Marie I, Dominique S, Levesque H et al (2001) Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 45:346–354. https://doi.org/10.1002/1529-0131(200108)45:4%3c346::AID-ART347%3e3.0.CO;2-L
doi: 10.1002/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L
pubmed: 11501722